PhD student at the Department of Epidemiology, Biostatistics and Occupational Health
Award-winning publication: A systematic review of biomarkers to detect active tuberculosis
Published in: Nature Microbiology
Each year, millions of cases of tuberculosis go undiagnosed. Current tests remain too slow, inaccurate, too costly or unavailable where most patient seek treatment. The World Health Organization therefore recommended the development of diagnostic tools that rely on biomarkers. Emily MacLean conducted the very first systematic study of this less explored field of tuberculosis biomarkers. The data from her study may be used to establish a dynamic online database aimed at helping researchers and diagnostic tool developers design and refine new tests that consider these biomarkers. Ultimately, the study constitutes a major step toward the implementation of research priorities in the field.